Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Respiratory Viral Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Not applicableActive Not RecruitingNCT05913700
What this trial is testing

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Viral InfectionAcute Disease
Institute for Clinical Effectiveness, Japan 3,067
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableLooking for participantsNCT07682844
What this trial is testing

Respiratory Physiotherapy and Hospitalization in Infants With Bronchiolitis

Who this might be right for
Acute Viral Bronchiolitis
University of Sao Paulo 1,000
Not applicableStudy completedNCT04527432
What this trial is testing

COVID-19 Health Professional Impact Study

Who this might be right for
Coronavirus InfectionSevere Acute Respiratory Syndrome
The Royal Wolverhampton Hospitals NHS Trust 1,504
Not applicableStudy completedNCT02460614
What this trial is testing

Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis

Who this might be right for
Acute Viral Bronchiolitis
Pontificia Universidade Católica do Rio Grande do Sul 100
Testing effectiveness (Phase 2)Ended earlyNCT04954014
What this trial is testing

Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients

Who this might be right for
ARDS, HumanCoronavirus Infection
Maimónides Biomedical Research Institute of Córdoba 21
Not applicableStudy completedNCT03976895
What this trial is testing

Prone Position in Acute Bronchiolitis

Who this might be right for
Acute Viral Bronchiolitis
Hospices Civils de Lyon 452
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Large-scale testing (Phase 3)Study completedNCT05543616
What this trial is testing

Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Who this might be right for
SARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19
BioNTech SE 4,338
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Not applicableStudy completedNCT04516928
What this trial is testing

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel

Who this might be right for
SARS-CoV InfectionCovid19
Direction Centrale du Service de Santé des Armées 392
Large-scale testing (Phase 3)Study completedNCT04501978
What this trial is testing

ACTIV-3: Therapeutics for Inpatients With COVID-19

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 2,753
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Large-scale testing (Phase 3)Study completedNCT03191097
What this trial is testing

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Who this might be right for
Influenza, HumanAcute Respiratory InfectionViral Infection+1 more
Valenta Pharm JSC 310
Not applicableStudy completedNCT06278324
What this trial is testing

Effectiveness of a Nasal Spray on Viral Respiratory Infections

Who this might be right for
Acute Respiratory Tract InfectionFlu, HumanCOVID-19+1 more
CEN Biotech 76
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Not applicableStudy completedNCT05765591
What this trial is testing

Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome

Who this might be right for
Post-COVID-19 Syndrome
Parc de Salut Mar 98
Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246
Next Page